Longevity leap: mind the healthspan gap.
Armin GarmanySatsuki YamadaAndre TerzicPublished in: NPJ Regenerative medicine (2021)
Life expectancy has increased by three decades since the mid-twentieth century. Parallel healthspan expansion has however not followed, largely impeded by the pandemic of chronic diseases afflicting a growing older population. The lag in quality of life is a recognized challenge that calls for prioritization of disease-free longevity. Contemporary communal, clinical and research trends aspiring to extend the health horizon are here outlined in the context of an evolving epidemiology. A shared action integrating public and societal endeavors with emerging interventions that target age-related multimorbidity and frailty is needed. A multidimensional buildout of a curative perspective, boosted by modern anti-senescent and regenerative technology with augmented decision making, would require dedicated resources and cost-effective validation to responsibly bridge the healthspan-lifespan gap for a future of equitable global wellbeing.
Keyphrases
- decision making
- healthcare
- community dwelling
- mental health
- physical activity
- stem cells
- sars cov
- coronavirus disease
- public health
- drosophila melanogaster
- mesenchymal stem cells
- cell therapy
- current status
- risk factors
- rectal cancer
- health information
- tissue engineering
- middle aged
- virtual reality
- risk assessment
- social media
- emergency medical